Jin Yang Pharmaceutical Co. Ltd (007370) — Cash Flow-to-Debt Ratio
Jin Yang Pharmaceutical Co. Ltd (007370) has a Cash Flow-to-Debt Ratio of -0.03x as of December 2025, meaning its operating cash flow of ₩-3.47 Billion could theoretically repay 0% of its total liabilities (₩107.95 Billion) in one year. See 007370 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jin Yang Pharmaceutical Co. Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Jin Yang Pharmaceutical Co. Ltd across 12 annual periods. Also explore 007370 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Jin Yang Pharmaceutical Co. Ltd (2014–2025)
Year-by-year debt coverage analysis for Jin Yang Pharmaceutical Co. Ltd. For market capitalisation and broader financial context, see 007370 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | ₩1.46 Billion | ₩107.95 Billion | ▼ -88.6% |
| 2024 | 0.12x | ₩12.79 Billion | ₩107.70 Billion | ▼ -57.8% |
| 2023 | 0.28x | ₩8.53 Billion | ₩30.32 Billion | ▲ +39.3% |
| 2022 | 0.20x | ₩7.45 Billion | ₩36.87 Billion | ▲ +240.2% |
| 2021 | 0.06x | ₩1.97 Billion | ₩33.18 Billion | ▼ -79.3% |
| 2020 | 0.29x | ₩6.24 Billion | ₩21.77 Billion | ▼ -2.1% |
| 2019 | 0.29x | ₩7.21 Billion | ₩24.61 Billion | ▲ +675.1% |
| 2018 | 0.04x | ₩1.06 Billion | ₩28.01 Billion | ▲ +220.5% |
| 2017 | -0.03x | ₩-987.16 Million | ₩31.47 Billion | ▼ -6337.5% |
| 2016 | 0.00x | ₩-13.47 Million | ₩27.64 Billion | ▲ +99.5% |
| 2015 | -0.10x | ₩-2.76 Billion | ₩27.72 Billion | ▲ +50.9% |
| 2014 | -0.20x | ₩-3.08 Billion | ₩15.20 Billion | — |